2m 2m 2m 2m 2m 2m 2m
XENETIC BIOSCS (XBIO)
NASDAQ
$3.31-$0.07 (-2.22%)
Price as of Jun 03, 2026 4:25 PM EDT- $7.2MMarket Cap
- 9.05%1-Year Change
- BiotechnologyIndustry
XENETIC BIOSCS (XBIO)
$3.31-$0.07 (-2.22%)
XBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.38 | ||
Change | +$0.07 (+2.11%) | ||
Open | $3.29 | ||
High | $3.45 | ||
Low | $3.28 | ||
Previous Close | $3.31 | ||
Volume | 39,454 | ||
30-Day Average Volume | 14,557 | ||
1-Week Change | 10.24% | ||
1-Month Change | 13.80% | ||
1-Year Change | 9.05% | ||
3-Year Change | 5.96% | ||
5-Year Change | -83.43% | ||
Fundamentals | |||
Shares Outstanding | 2.3M | ||
Total Assets | $7.9M | ||
Market Cap | $7.2M | ||
Enterprise Value | -$130,429.00 | ||
Period: QTR TTM FY | |||
Revenue | $806,923.00 | ||
Net Income | N/A | ||
Free Cash Flow | -$536,377.00 | ||
EBIT | $0.00 | ||
EBITDA | $0.00 | ||
Net Working Capital | $6.6M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | -0 | ||
P/B | 1 | ||
P/E | -16 | ||
PEG | N/A | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 05/15/2023 | ||
Earnings & Revenue